Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
11/2009
11/03/2009US7612075 Anticaogulants; cardiovascular disorders
11/03/2009US7612070 Indole derivative having heterocycle and mono- or diazaindole derivative
11/03/2009US7612064 Sulfopyrroles
11/03/2009US7612060 (R)-3-((1-((R)-7-cyclopropylaminomethyl-3,4-dihydro-2H-chromen-4-yl)-1H-1,2,3-triazol-4-yl)methyl)-4-(4-methylbenzenesulfonyl)-3,4-dihydropyrazin-2(1H)-one; pain, inflammation
11/03/2009US7612059 Pyrrolidine bicyclic compounds and its derivatives, compositions and methods of use
11/03/2009CA2420585C Amides of r-2-(aminoaryl)-propionic acids for use in the prevention of leucocyte activation
10/2009
10/29/2009WO2009132202A2 Macrocyclic compounds and their use as kinase inhibitors
10/29/2009WO2009131815A1 1,5-diphenyl-pyrrolidin-2-one compounds as cb-1 ligands
10/29/2009WO2009131687A2 Inhibitors of protein kinases
10/29/2009WO2009131669A2 Carbamate and urea inhibitors of 11beta-hydroxysteroid dehydrogenase 1
10/29/2009WO2009131657A1 Asymmetric alpha functionalization and alpha, alpha bisfunctionalization of aldehydes and ketones
10/29/2009WO2009131598A1 Heterocyclic compounds
10/29/2009WO2009131196A1 Substituted pyrrolidine derivative and use thereof
10/29/2009WO2009131173A1 2-aminoquinazoline derivative
10/29/2009WO2009131096A1 Compound having npy y5 receptor antagonist activity
10/29/2009WO2009131065A1 Long-chain fatty acid elongation enzyme inhibitor comprising arylsulfonyl derivative as active ingredient
10/29/2009WO2009130496A1 Substituted pyrimidin-5-carboxamides 281
10/29/2009WO2009130310A1 1-aryl-3-aminoalkoxy pyrazoles as sigma ligands enhancing analgesic effect of opioids and attenuating the dependency thereof
10/29/2009WO2009130240A1 Isoquinolinone derivatives as nk3 antagonists
10/29/2009WO2009130234A1 (5r)-1,5-diaryl-4,5-dihydro-1h-pyrazole-3-carboxamidine derivatives having cb1-antagonistic activity
10/29/2009WO2009130193A1 Fungicide hydroximoyl-heterocycles derivatives
10/29/2009WO2009129945A1 Substituted dihydropyrazolones as inhibitors of hif-prolyl-4-hydroxylases
10/29/2009WO2009129905A1 Pyridazinone derivatives
10/29/2009WO2009129696A1 A kind of receptor signaling transoluction positive modulators, preparation methods and uses thereof
10/29/2009WO2009129625A1 Novel substituted heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase
10/29/2009WO2009109782A3 Polycyclic organic compounds, retardation layer and compensation panel based thereon
10/29/2009WO2009106980A3 Indazole derivatives
10/29/2009WO2009105504A3 Functionally selective alpha2c adrenoreceptor agonists
10/29/2009US20090270638 Methods and intermediates for the synthesis of porphyrins
10/29/2009US20090270621 N-4-[3-Chloro-4-(3-fluoro-benzyloxy)-phenyl]-N6-(3-ethyl-oxazolidin-2-ylidene)-quinazoline-4,6-diamine; use as type I receptor tyrosine kinase inhibitor; hyperproliferation diseases such as cancer; antiinflammatory agents
10/29/2009US20090270617 Phthalazinone derivative
10/29/2009US20090270613 5-Fluoro-4-methyl-2-{2-[4-(4-methyl-piperazin-1-yl)-butoxy]-pyridin-4-yl}-1H-benzoimidazole; leukocyte recruitment inhibition, modulating H4 receptor, and treating conditions such as inflammation
10/29/2009US20090270611 Benzoimidazole compounds
10/29/2009US20090270536 Oligomeric sterically hindered amines and their use as polymer stabilisers
10/29/2009US20090270454 Sulfonamide containing compounds for treatment of inflammatory disorders
10/29/2009US20090270419 Combinations of class-i specific histone deacetylase inhibitors with proteasome inhibitors
10/29/2009US20090270418 Pyrazole pyrazine amine compounds as kinase inhibitors, compositions thereof and methods of treatment therewith
10/29/2009US20090270417 Organic Compounds
10/29/2009US20090270415 Compounds that inhibit protease cathepsin s and hcv replication
10/29/2009US20090270414 2,3,4,9- tetrahydro-1h-carbazole derivatives as crth2 receptor antagonists
10/29/2009US20090270411 Phenanthridine derivatives as bradykinin antagonists
10/29/2009US20090270403 Novel 1,4-diaza-bicyclo[3.2.2]nonyl pyrimidinyl derivative and its medical use
10/29/2009US20090270372 Melanocortin receptor MC4 modulators; obesity, sexual disorders, anxiolytic agents, analgesics, antidepressants; 6-(aminomethyl)-2-aminobenzimidazole derivatives
10/29/2009US20090270367 Substituted hydroxyethylamine aspartyl protease inhibitors
10/29/2009US20090270366 Benzoimidazole compounds
10/29/2009US20090270361 Substituted pyrazole derivatives and use thereof
10/29/2009US20090269420 Substituted dihydropyrazolones and their use
10/29/2009US20090269301 Novel Inhibitors of Glutaminyl Cyclase
10/29/2009DE102008020113A1 Substituierte Dihydropyrazolone und ihre Verwendung Substituted dihydropyrazolones and their use
10/29/2009CA2723185A1 Inhibitors of protein kinases
10/29/2009CA2722345A1 1-aryl-3-aminoalkoxy pyrazoles as sigma ligands enhancing analgesic effect of opioids and attenuating the dependency thereof
10/29/2009CA2722326A1 Macrocyclic compounds and their use as kinase inhibitors
10/29/2009CA2722159A1 Substituted phenylimidazole compounds and their use as ido inhibitors
10/29/2009CA2722075A1 Long-chain fatty acyl elongase inhibitor comprising arylsulfonyl derivative as active ingredient
10/29/2009CA2721908A1 (5r)-1,5-diaryl-4,5-dihydro-1h-pyrazole-3-carboxamidine derivatives having cb1-antagonistic activity
10/29/2009CA2721858A1 Pyridazinone derivatives
10/29/2009CA2721750A1 Carbamate and urea inhibitors of 11beta-hydroxysteroid dehydrogenase 1
10/29/2009CA2721576A1 Compound having npy y5 receptor antagonist activity
10/29/2009CA2721542A1 1,5-diphenyl-pyrrolidin-2-one compounds as cb-1 ligands
10/29/2009CA2721260A1 Isoquinolinone derivatives as nk3 antagonists
10/29/2009CA2720654A1 Novel substituted heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase
10/29/2009CA2720229A1 Heterocyclic compounds
10/29/2009CA2719936A1 Substituted pyrimidin-5-carboxamides 281
10/28/2009EP2112671A1 A dye including an anchoring group in its molecular structure
10/28/2009EP2112148A1 Solid salt forms of a pyrrole substituted 2-indolinone
10/28/2009EP2111396A1 Hcv inhibiting macrocyclic phenylcarbamates
10/28/2009EP2111394A1 Compounds with a combination of cannabinoid-cb1 antagonism and serotonin reuptake inhibition
10/28/2009EP1786779B1 4-arylazo-3,5-diamino-pyrazole compounds and use thereof
10/28/2009CN101568535A Aminopyridines and aminopyrimidines useful as inhibitors of protein kinases
10/28/2009CN101568534A Benzoyl amino heterocyclyl compounds useful in the treatment of a disease mediated through GLK
10/28/2009CN101568532A Cyclic derivatives as modulators of chemokine receptor activity
10/28/2009CN101568530A Indol-4-yl-pyrimidinyl-2-yl-amine derivatives and use thereof as cyclin dependant kinase inhibitors
10/28/2009CN101568529A Heteroaryl-heteroaryl compounds as cdk inhibitors for the treatment of cancer, inflammation and viral infections
10/28/2009CN101568525A Cb1 receptor modulators
10/28/2009CN101565404A Heterocyclic compounds
10/28/2009CN100554265C N-(4-bromo-2- fluorobenzene)-6-methox-7-[2(1H-1,2,3-1- triazole) ethoxy]-4-quinazoline amine hydrochloric acid synthesis and uses
10/28/2009CN100554264C Pyrazolyl and imidazolyl pyrimidines
10/27/2009US7609279 Data-driven layout engine
10/27/2009US7608731 Phenylacetic acid compounds
10/27/2009US7608722 reacting N-methyl-o-phenylenediamine with 2-propyl-4-methyl-1H-benzimidazole-6-carboxylic acid, coupling and cyclization is achieved using 1,3,5-triazine ( 2-chloro-4,6-dimethoxy-1,3,5-triazine) and tertiary amine ( morpholine, N-methyl-)
10/27/2009US7608718 4,5-dihydro-1H-pyrazole derivatives having potent CB1-antagonistic activity
10/27/2009US7608634 Substituted pyrrolines as kinase inhibitors
10/27/2009US7608632 Sulfonamide inhibitors of aspartyl protease
10/27/2009US7608621 Such as n-{[2-[(4-bromo-2-fluorophenyl)methyl]-5-hydroxy-6-(1-methylethyl)-3-oxo-2,3-dihydro-4-pyridazinyl]carbonyl}glycine; anemia; increasing erythropoietin production
10/27/2009US7608618 1-(2,2,2-trifluoroethanoyl)pyrrolidine-2-carboxylic acid [4-methoxy-3-(3-pyrazin-2-yl-ureido)phenyl]-amide; 4-Methoxy-N-(3-methylamino-propyl)-3-(3-pyrazin-2-yl-ureido)-benzamide; checkpoint kinase Chk1 inhibitor; chemosensitizing agents useful in the treatment of diseases related to DNA damage
10/27/2009US7608615 Pyrrolo[2,1-C][1,4]benzodiazepine hybrids and a process for the preparation thereof
10/27/2009US7608564 Herbicide; in crops such as wheat, rice, maize, soybeans and cotton they act against broad-leaved weeds and grass weeds without damaging the crop plants; compounds are based on 3-(5,5-disubstituted 2-isoxazolin-3-yl)benzoic acid, esters, thioesters and pyrazolyl ketones thereof
10/27/2009US7608563 3-phenoxy-4-pyridazinol derivatives and herbicide composition containing the same
10/27/2009CA2506441C 5-substituted-pyrazine or pyridine glucokinase activators
10/27/2009CA2419665C Novel 2-phenylpiperazine derivatives
10/27/2009CA2379021C New phenylpiperazines
10/27/2009CA2376355C N-heterocyclic derivatives as nos inhibitors
10/27/2009CA2363792C Percutaneous absorption preparation of compound having angiotensin ii antagonistic activity
10/27/2009CA2361174C 4-amino-quinazoline and quinoline derivatives having an inhibitory effect on signal transduction mediated by tyrosine kinases
10/24/2009CA2683209A1 Pyrimidinones as casein kinase ii (ck2) modulators
10/22/2009WO2009129109A1 Hepatitis c virus inhibitors
10/22/2009WO2009128547A1 Gene expression inhibitor selective for matrix metalloproteinase-9 gene
10/22/2009WO2009128083A1 Novel polymorphic forms of sunitinib base
10/22/2009WO2009127686A1 Novel estrogen receptor ligands
10/22/2009WO2009127642A2 Use of lrrk2 inhibitors for neurodegenerative diseases
1 ... 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 ... 626